Managing Cardiovascular and Cancer Risk Associated with JAK Inhibitors.

Yang V, Kragstrup TW, McMaster C, Reid P, Singh N, Haysen SR, Robinson PC, Liew DFL

DOI: 10.1007/s40264-023-01333-0
Published: 2023 Nov
Container: Drug safety
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1007/s40264-023-01333-0,
  title = {Managing Cardiovascular and Cancer Risk Associated with JAK Inhibitors.},
  author = {Yang V and Kragstrup TW and McMaster C and Reid P and Singh N and Haysen SR and Robinson PC and Liew DFL},
  year = {2023},
  journal = {Drug safety},
  doi = {10.1007/s40264-023-01333-0},
  url = {https://doi.org/10.1007/s40264-023-01333-0}
}

RIS

TY  - JOUR
TI  - Managing Cardiovascular and Cancer Risk Associated with JAK Inhibitors.
AU  - Yang V
AU  - Kragstrup TW
AU  - McMaster C
AU  - Reid P
AU  - Singh N
AU  - Haysen SR
AU  - Robinson PC
AU  - Liew DFL
PY  - 2023
JO  - Drug safety
DO  - 10.1007/s40264-023-01333-0
UR  - https://doi.org/10.1007/s40264-023-01333-0
ER  -

APA

V, Y., TW, K., C, M., P, R., N, S., SR, H., PC, R., & DFL, L. (2023). Managing Cardiovascular and Cancer Risk Associated with JAK Inhibitors.. Drug safety. https://doi.org/10.1007/s40264-023-01333-0

Source records

pubmed · retrieved 2026-09-26T23:52:37.876Z